ETHYL 2-ETHYLPYRIMIDINE-5-CARBOXYLATE, 95.0%, 1g

3-(4-(Trifluoromethoxy)phenyl)piperidine, 250mg

(4-((3-FLUOROBENZYL)OXY)PHENYL)METHANOL, 95%, 5g

1H-Pyrrolo[2,3-b]pyridine, 4-chloro-2-iodo-1-[(4-methylphenyl)sulfonyl]-, 95%, 1g

CLINAFLOXACIN, 95%, 50mg

Decalcificante morbido, 2,5 l, plastica

Tofacitinib metabolite-1, 5mg

Tetrabutylammonium hydrogencarbonate, 95%, 10g

Recipiente di reazione a flangia piatta cilindrico, graduato (1) Fondo tondo, DN 100, 105 mm, Altezza, 140 mm, 1 Pezzo

1,4-Dinitrobenzene>99.0%(GC)5g

3',5'-Dichloro-biphenyl-4-carboxylic acid, 95.0%, 5g

N-(Chloromethyl)phthalimide, 97.0%, 500g

1,1'-Dibenzoylferrocene, 95.0%, 25g